Home > Financial Ratios > AARTI PHARMALABS

AARTI PHARMALABS
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for AARTI PHARMALABS
Please provide your vote to see the results

AARTI PHARMALABS Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) 21.9620.8417.5817.11-

What is the latest Core EBITDA Margin ratio of AARTI PHARMALABS ?

The latest Core EBITDA Margin ratio of AARTI PHARMALABS is 21.96 based on Mar2025 Consolidated results.
Year Core EBITDA Margin
Mar202521.96
Mar202420.84
Mar202317.58
Mar202217.11
Mar2021-

How is Core EBITDA Margin of AARTI PHARMALABS Trending?

Years Core EBITDA Margin % Change
Mar2025 21.96
5.37
Mar2024 20.84
18.54
Mar2023 17.58
2.75
Mar2022 17.11
0
Mar2021 0 -

Other Financial Ratios of AARTI PHARMALABS


Compare Core EBITDA Margin ratio of peers of AARTI PHARMALABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI PHARMALABS ₹5,646.5 Cr -5.1% -22.7% -27.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹429,349.0 Cr -3% -1.9% 7.5% Stock Analytics
DIVIS LABORATORIES ₹174,543.0 Cr -3.3% -0.7% -1.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹147,884.0 Cr -3.8% 2.8% 36.4% Stock Analytics
CIPLA ₹111,077.0 Cr -3% 3% -6.1% Stock Analytics
DR REDDYS LABORATORIES ₹105,388.0 Cr -4.3% -2% 2.5% Stock Analytics


AARTI PHARMALABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI PHARMALABS

-5.1%

-22.7%

-27.1%

SENSEX

-2.2%

-3.3%

-8.8%


You may also like the below Video Courses